Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Laboratory Evaluation for Brain Fog and Cognitive Impairment

Initial Laboratory Assessment

  • The American Academy of Neurology recommends lipid panel to assess cardiovascular risk factors that may contribute to vascular cognitive impairment 1
  • The American Diabetes Association suggests HbA1c to evaluate for diabetes or pre-diabetes 2

Specialized Testing Based on Clinical Suspicion

  • The Centers for Disease Control and Prevention recommends HIV testing in patients with risk factors 1
  • The American Heart Association suggests RPR or VDRL to rule out neurosyphilis in appropriate cases 2

Advanced Testing for Persistent or Progressive Symptoms

  • The National Institute on Aging recommends cerebrospinal fluid biomarkers for Alzheimer's disease (Aβ1-42, total tau, and phosphorylated tau) in patients with persistent cognitive symptoms suggestive of neurodegenerative disease 5, 6
  • The American Academy of Neurology suggests cognitive screening using validated tools like MoCA (Montreal Cognitive Assessment) or SLUMS (Saint Louis University Mental Status) to accompany laboratory evaluation 1, 3

Interpretation and Follow-up

  • The American Medical Association recommends that laboratory abnormalities should be interpreted in the context of the patient's clinical presentation, and normal laboratory results do not rule out cognitive impairment; further evaluation may be needed 1, 2

Special Considerations

  • The American Geriatrics Society suggests considering a lower threshold for CSF biomarker testing or referral to a memory specialist in older adults (>65 years) 5, 6
  • The American Academy of Sleep Medicine recommends considering sleep study referral if sleep apnea is suspected, as this can significantly contribute to cognitive complaints 3, 4